Drug Database
Back to search

Poland· PL-100327956

Ginkofar Extra

A medicinal product containing ginkgonis extractum siccum raffinatum et quantificatum, registered in Poland by Biofarm Sp. z o.o..

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedGinkofar ExtraATC—REGISTER NO.PL-100327956PACKS LISTED7CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ginkgonis extractum siccum raffinatum et quantificatumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

URPL (Poland)
Active substance
Ginkgonis extractum siccum raffinatum et quantificatum
Manufacturer
Biofarm Sp. z o.o.
Country
Poland (PL)
ATC code
—
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 7

  • gtin
    05909991197223
  • gtin
    05909991197162
  • gtin
    05909991197179
  • gtin
    05909991197186
  • gtin
    05909991197193
  • gtin
    05909991197209
  • gtin
    05909991197216

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ginkgonis extractum siccum raffinatum et quantificatum in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ginkgonis extractum siccum raffinatum et quantificatum products

Authorised across Europe · EMA

The same active substance is authorised in 9 EEA countries. Names it is sold under:

  • Germany · Synapsan
  • Denmark · Bio-Biloba
  • Estonia · Bio-Biloba
  • Spain · Incebral
  • France · Vitalogink
  • Croatia · Bilobil Intense
  • Hungary · Tebofortan
  • Portugal · Abolibe Forte, Biloban
  • Slovakia · Gingio

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e2c1d42f-2ed4-4578-ac61-2bf09621a1d8
GET /v1/drugs/e2c1d42f-2ed4-4578-ac61-2bf09621a1d8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "240 mg",
  "packaging": "05909991197162 ¦ OTC ¦ 105094\n30 tabl.\n05909991197179 ¦ OTC ¦ 105095\n90 tabl.\n05909991197186 ¦ OTC ¦ 105096\n20 tabl.\n05909991197193 ¦ OTC ¦ 105097\n10 tabl.\n05909991197209 ¦ OTC ¦ 105098\n60 tabl.\n05909991197216 ¦ OTC ¦ 105099\n50 tabl.\n05909991197223 ¦ OTC ¦ 105100\n40 tabl.",
  "substance": "Ginkgonis extractum siccum raffinatum et quantificatum 240 mg",
  "common_name": "Ginkgonis extractum siccum raffinatum et quantificatum",
  "pl_product_id": "100327956",
  "pozwolenie_nr": "22781",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about ginkgonis extractum siccum raffinatum et quantificatum.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console